Mankind Pharma

Mankind Pharma enters US market with investment of approx Rs 300 crores

Read more

Mankind Pharma to open two plants by mid-2016

Read more

Mankind Pharma launches anti-diabetic product Dynaglipt

Read more

Mankind Pharma invests Rs 150 cr in Paonta Sahib plant

Read more

Mankind Pharma’s ‘D3 Must Campaign’ promotes for stronger bones

Read more

Mankind’s Next Force

Read more

When patience is not a virtue

Read more

Mankind Pharma launches ‘Heal-o-Kind’ for topical wounds

Read more